[PDF][PDF] Achieving “Zero” defects for visible particles in injectables
J Johns, P Golfetto, T Bush, G Fantozzi… - PDA Journal of …, 2018 - scholar.archive.org
The reduction of visible particles in injectable products is an important element in the consistent
delivery of high-quality parenteral products. An important part of this effort is the control …
delivery of high-quality parenteral products. An important part of this effort is the control …
Points to Consider: Best Practices to Identify Particle Entry Routes along the Manufacturing Process for Parenteral Formulations
S Anger, C Begat, V Crnko, GM Fantozzi… - PDA Journal of …, 2019 - journal.pda.org
During the processes involved in pharmaceutical manufacturing, particulate matter may be
introduced into a product from a variety of sources and at different points in the manufacturing …
introduced into a product from a variety of sources and at different points in the manufacturing …